NCT05078827
Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis
Phase: Phase 3
Role: Lead Sponsor
Start: Mar 1, 2022
Completion: Dec 1, 2022